{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:33:05Z","timestamp":1778113985746,"version":"3.51.4"},"reference-count":29,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>According to the revision of the FIGO 2018 staging system, cervical cancer with pelvic lymph node metastases was changed to stage IIIC1. We retrospectively analyzed the prognosis and complications of locally resectable (classified as T1\/T2 by TNM classification of the Union for International Cancer Control) stage IIIC1 cervical cancer. A total of 43 patients were divided into three groups: surgery with chemotherapy (CT) (ope+CT group) (T1; n = 7, T2; n = 16), surgery followed by concurrent chemoradiotherapy (CCRT), or radiotherapy (RT) (ope+RT group) (T1; n = 5, T2; n = 9), and CCRT or RT alone (RT group) (T1; n = 0, T2; n = 6). In T1 patients, recurrence was observed in three patients, but there was no difference among the treatment groups, and no patients died. In contrast, in T2 patients, recurrence and death were observed in nine patients (8 in ope+CT; 1 in ope+RT), and recurrence-free survival and overall survival were lower in the ope+CT group (p = 0.02 and 0.04, respectively). Lymphedema and dysuria were more common in the ope+RT group. A randomized controlled trial comparing CT and CCRT as an adjuvant therapy after surgery in T1\/T2 patients, including those with pelvic lymph node metastases, is currently underway. However, our data suggest that performing CT alone after surgery in T2N1 patients is likely to worsen the prognosis.<\/jats:p>","DOI":"10.3390\/healthcare11050632","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T03:59:16Z","timestamp":1677038356000},"page":"632","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study"],"prefix":"10.3390","volume":"11","author":[{"given":"Yoko","family":"Kashima","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Sayama 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-5849","authenticated-orcid":false,"given":"Kosuke","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Sayama 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9614-0117","authenticated-orcid":false,"given":"Chiho","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Sayama 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisamitsu","family":"Takaya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Sayama 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kotani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Sayama 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekatsu","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Sayama 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4512-7975","authenticated-orcid":false,"given":"Noriomi","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Sayama 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/cas.15320","article-title":"Trends in cervical cancer incidence and mortality of young and middle adults in Japan","volume":"113","author":"Tanaka","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(20)30157-4","article-title":"Mortality impact of achieving WHO cervical cancer elimination targets: A comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Canfell","year":"2020","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: A comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1470-2045(22)00002-X","article-title":"Japan resumes active recommendations of HPV vaccine after 8\u00b75 years of suspension","volume":"23","author":"Haruyama","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15330338221086403","DOI":"10.1177\/15330338221086403","article-title":"Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review","volume":"21","author":"Qin","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21199","article-title":"Lymph node assessment in cervical cancer: Prognostic and therapeutic implications","volume":"99","author":"Gien","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10147-010-0123-0","article-title":"Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy","volume":"16","author":"Hosaka","year":"2011","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/gyno.2000.5788","article-title":"High-Risk Group in Node-Positive Patients with Stage IB, IIA, and IIB Cervical Carcinoma after Radical Hysterectomy and Postoperative Pelvic Irradiation","volume":"77","author":"Aoki","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_11","unstructured":"National Comprehensive Cancer Network (2023, February 18). Cervical Cancer (Version 1). Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10147-015-0806-7","article-title":"Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer","volume":"20","author":"Ebina","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-018-1351-y","article-title":"Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer","volume":"24","author":"Ebina","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_14","unstructured":"Japan Society of Gynecologic Oncology (2022). Guidelines for Treatment of Uterine Cervical Cancer, Japan Society of Gynecologic Oncology (JSGO). (In Japanese)."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: A randomized controlled trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1200\/JCO.2019.37.15_suppl.5503","article-title":"Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for stage Ib2-IIb cervical cancer, EORTC 55994","volume":"15","author":"Kenter","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Brierley, J.D., Gospodarowicz, M.K., and Wittekind, C. (2017). TNM Classification of Malignant Tumours, John Wiley & Sons. [8th ed.].","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"ref_18","first-page":"498","article-title":"Outcomes of abandoned radical hysterectomy in patients with stages IB-IIA cervical cancer found to have positive nodes during the operation","volume":"15","author":"Suprasert","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2020.10.037","article-title":"Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study","volume":"143","author":"Cibula","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/jog.14816","article-title":"Treatment strategy for locally advanced squamous cell cervical cancer with clinically positive pelvic lymph nodes metastasis","volume":"47","author":"Shibutani","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1016\/j.ejca.2012.05.011","article-title":"Quality of life characteristics in patients with cervical cancer","volume":"48","author":"Jensen","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jrr\/rraa107","article-title":"A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: A comparison between radical radiotherapy and surgery in Japan","volume":"62","author":"Kaneyasu","year":"2021","journal-title":"J. Radiat. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2018.04.009","article-title":"Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067)","volume":"149","author":"Matoda","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ijgc-2020-002344","article-title":"A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)","volume":"31","author":"Furusawa","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijgo.2010.08.016","article-title":"Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma","volume":"112","author":"Chen","year":"2011","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ygyno.2014.01.043","article-title":"Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: A multicenter retrospective study (KROG 13-10)","volume":"132","author":"Noh","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1447-0756.2010.01275.x","article-title":"Postoperative concurrent chemoradiotherapy for the high-risk uterine cervical cancer","volume":"36","author":"Takeshita","year":"2010","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ijc.30793","article-title":"Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation","volume":"141","author":"Matsuo","year":"2017","journal-title":"Int. J. Cancer"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/5\/632\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:38:08Z","timestamp":1760121488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/5\/632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["healthcare11050632"],"URL":"https:\/\/doi.org\/10.3390\/healthcare11050632","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}